|
For researchers, well-characterized human samples are valuable commodities. And that’s exactly what Novaseek Research delivers to its customers Novaseek’s CEO Kate Torchilin told Clinical Informatics News last month at a meeting in Boston. “Having the biospecimen is very important here,” she said. “You can only deduce so much from data.” Click to read more.
Comments are closed.
|
